AzurRx Biopharma (AZRX) PT Raised to $8 at Oppenheimer Following Physician Survey
Tweet Send to a Friend
Oppenheimer analyst Leland Gershell raised the price target on AzurRx Biopharma (NASDAQ: AZRX) to $8.00 (from $6.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
